NCT02589158 - SSAT067 PK of Atazanavir/Cobicistat and Darunavir/Cobicistat | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

HIV

Interventions

DRUG

Evotaz

All participants will be administered Evotaz®) (atazanavir 300mg + cobicistat 150mg) once daily for 10 days

DRUG

Rezolsta

All participants will be administered Rezolsta® (darunavir 800mg + cobicistat 150mg) once daily for 10 days.

Trial Locations (1)

St Stephen's Centre, Chelsea and Westminster Hospital NHS Foundation Trust, London